TruLeaf from the AllMeD Solutions group, successfully completed the first phase of a first-in-human clinical trial of a revolutionary system for tricuspid and mitral heart valve implantation via catheter only CAESAREA, Israel, Sept. 10, 2025 /PRNewswire/ — AllMeD Solutions (TASE: ALMD),…
